STOCK TITAN

Soleus Capital (NASDAQ: CERS) discloses 5.1% position in Cerus

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Soleus Capital Master Fund, L.P. and affiliated filers report beneficial ownership of 9,828,700 shares of Cerus Corporation common stock, representing 5.1% of the class based on 192,171,776 shares outstanding as of February 5, 2026.

The filing indicates shared voting and shared dispositive power over 9,828,700 shares among Soleus entities and Guy Levy. The filers state the shares are held directly by the Master Fund and include a standard disclaimer that affiliated entities and Mr. Levy disclaim beneficial ownership except for purposes of Section 13(d).

Positive

  • None.

Negative

  • None.

Insights

Large institutional stake disclosed: 9,828,700 shares (5.1%).

The filing lists a 9,828,700-share position held directly by Soleus Capital Master Fund, representing 5.1% of the outstanding common stock using the Issuer's stated 192,171,776 share count as of February 5, 2026. The ownership is recorded as shared voting and shared dispositive power.

The economic and voting influence depends on Soleus's future decisions; subsequent filings would show changes. Timing and transaction intent are not stated in this excerpt.

Ownership structure shows layered entity relationships and standard disclaimers.

The schedule explains the ownership chain: the Master Fund holds the shares; Soleus Capital (general partner), Soleus Capital Group, Soleus Capital Management, Soleus GP, LLC and Guy Levy are disclosed as related persons. The filing includes a disclaimer limiting beneficial ownership attribution to Section 13(d) purposes.

Governance implications hinge on whether Soleus exercises shared voting power; any coordinated activity or changes in voting would appear in future Section 13 filings or public disclosures.






157085101

(CUSIP Number)
03/23/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC ("Soleus Capital") is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, Soleus Capital Management, L.P. ("SCM") is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of Cerus Corporation (the "Issuer") outstanding as of February 5, 2026, as reported on the cover of the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on March 2, 2026 (the "Form 10-K").


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of the Issuer outstanding as of February 5, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of the Issuer outstanding as of February 5, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of the Issuer outstanding as of February 5, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of the Issuer outstanding as of February 5, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons \s the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 192,171,776 shares of the common stock of the Issuer outstanding as of February 5, 2026, as set forth on the cover of the Form 10-K.


SCHEDULE 13G



Soleus Capital Master Fund, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:03/24/2026
Soleus Capital, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:03/24/2026
Soleus Capital Group, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:03/24/2026
Soleus Capital Management, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:03/24/2026
Soleus GP, LLC
Signature:Soleus GP, LLC
Name/Title:Guy Levy/Managing Member
Date:03/24/2026
Guy Levy
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:03/24/2026

Comments accompanying signature: Exhibit 99.A - Joint Filing Agreement

FAQ

What stake does Soleus Capital hold in Cerus (CERS)?

Soleus Capital Master Fund, L.P. reports ownership of 9,828,700 shares, equal to 5.1% of Cerus common stock based on 192,171,776 shares outstanding as of February 5, 2026. The shares are held directly by the Master Fund.

Who among the Soleus entities has voting power over Cerus shares?

The filing shows shared voting power of 9,828,700 shares across Soleus entities and Guy Levy. No entity claims sole voting or sole dispositive power; voting is reported as shared by the named filers.

Does Guy Levy personally own the Cerus shares reported?

The filing states the shares are held directly by Soleus Capital Master Fund, and Guy Levy and affiliated entities disclaim beneficial ownership

What outstanding share count does the filing use to calculate the ownership percentage?

The percentage is calculated using 192,171,776 shares outstanding

Will this Schedule 13G require Cerus to disclose changes?

A Schedule 13G reports passive or qualifying institutional ownership and does not itself mandate company disclosures. Any change in Soleus's holdings or voting intent would be reflected in subsequent Section 13 filings as required by the Exchange Act.
Cerus

NASDAQ:CERS

View CERS Stock Overview

CERS Rankings

CERS Latest News

CERS Latest SEC Filings

CERS Stock Data

330.54M
183.18M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CONCORD